 |
인쇄하기
취소
|
Pharmaceutical stock set fresh records
The stock price of Ilyang Pharm jumped about 200 percent for the consecutive seven days on hopes of stronger earnings, after the company reported in its official filing the approval of ilaprazole, a novel antiulcer agent.
Sources say the biggest gain was chiefly attributed to the fast-track approval system of the Korea Food and Drug Administration.
“Our timely approval for ilaprazole has ...
Sources say the biggest gain was chiefly attributed to the fast-track approval system of the Korea Food and Drug Administration.
“Our timely approval for ilaprazole has ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.